National Eye Institute | The Journey from Gene to Sight

Eliminate vision loss and improve quality of life through vision research –When decades of scientific discovery finally change what's possible for human sight, the story deserves to be told with care. We partnered with the National Eye Institute (NEI) — part of the federal government's National Institutes of Health — to bring that story to life on screen.

The film centers on Dr. T. Michael Redmond, a senior NEI investigator whose research into the RPE65 gene laid the scientific foundation for Luxturna: the first FDA-approved gene therapy for an inherited disease. For families living with Leber Congenital Amaurosis, a rare condition that causes blindness in early childhood, this breakthrough meant children who once faced inevitable vision loss could experience the world in ways previously unimaginable.

But the most powerful moment of the film wasn't scripted. On set, Dr. Redmond was surprised by two siblings whose lives had been transformed by his work — patients he had never met, whose sight had been restored because of research he had spent his career quietly pursuing. It's the kind of moment that reminds you why science matters: not in the abstract, but in the very human, very personal way it reshapes individual lives.

Our role was to translate complex, decades-long science into a compelling human narrative — honoring the rigor of the research while making it accessible and genuinely moving. The result is a film that captures not just a medical milestone, but the quiet persistence behind it, and the faces that make it real.